Literature DB >> 15111784

Good outcome for infant of mother treated with chemotherapy for ewing sarcoma at 25 to 30 weeks' gestation.

Wako Nakajima1, Akira Ishida, Maya Takahashi, Masashi Hirayama, Noriaki Washino, Masaki Ogawa, Shu Takahashi, Kyoji Okada.   

Abstract

There have been only three previous reports of women with Ewing sarcoma who received chemotherapy while pregnant. A 17-year-old woman with Ewing sarcoma was treated with a combination of doxorubicin (Adriamycin) and ifosfamide during the 25th to 30th week of gestation, and the baby was delivered at the 32nd week. The baby was developing normally at follow-up at 8 months of age. This case report supports the idea that in this situation, the pregnancy can be continued to await fetal growth, and second-trimester chemotherapy may not have a deleterious effect on the fetus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111784     DOI: 10.1097/00043426-200405000-00010

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  5 in total

Review 1.  Transplacental Passage and Fetal Effects of Antineoplastic Treatment during Pregnancy.

Authors:  Silvia Triarico; Serena Rivetti; Michele Antonio Capozza; Alberto Romano; Palma Maurizi; Stefano Mastrangelo; Giorgio Attinà; Antonio Ruggiero
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

2.  Sarcoma of the ewing family in pregnancy: a case report of intrauterine fetal death after induction of chemotherapy.

Authors:  S Schur; J Wild; G Amann; W Köstler; M Langer; T Brodowicz
Journal:  Case Rep Oncol       Date:  2012-09-27

3.  Delayed diagnosis of an Ewing sarcoma of the knee during pregnancy.

Authors:  M Verheecke; C Salembier; S Vanderlinden
Journal:  Facts Views Vis Obgyn       Date:  2013

Review 4.  Bone and soft tissue sarcomas during pregnancy: A narrative review of the literature.

Authors:  George Zarkavelis; Dimitrios Petrakis; George Fotopoulos; Sotirios Mitrou; Nicholas Pavlidis
Journal:  J Adv Res       Date:  2016-02-02       Impact factor: 10.479

5.  Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy.

Authors:  Devon Miller; John A Livingston; Yeonhee Park; Kristi Posey; Sonia Godbole; Keith Skubitz; Steven I Robinson; Mark Agulnik; Lara E Davis; Brian A Van Tine; Angela C Hirbe; Amanda Parkes
Journal:  Cancer Med       Date:  2022-03-28       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.